WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2010150280) DISUBSTITUTED BENZAMIDE DERIVATIVES AS GLUCOKINASE (GK) ACTIVATORS
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2010/150280    International Application No.:    PCT/IN2010/000426
Publication Date: 29.12.2010 International Filing Date: 21.06.2010
Chapter 2 Demand Filed:    03.01.2011    
IPC:
C07D 417/12 (2006.01), C07D 417/14 (2006.01), A61K 31/4245 (2006.01), A61K 31/427 (2006.01), A61P 3/10 (2006.01)
Applicants: CADILA HEALTHCARE LIMITED [IN/IN]; Zydus Tower Satellite Cross Road Ahmedabad 380015 Gujarat (IN) (For All Designated States Except US).
KHARUL, Rajendra [IN/IN]; (IN) (For US Only)
Inventors: KHARUL, Rajendra; (IN)
Agent: SUBRAMANIAM, Hariharan; Subramaniam, Nataraj & Associates E-556, Greater Kailash-II New Delhi 110 048 (IN)
Priority Data:
1480/MUM/2009 22.06.2009 IN
Title (EN) DISUBSTITUTED BENZAMIDE DERIVATIVES AS GLUCOKINASE (GK) ACTIVATORS
(FR) DÉRIVÉS DE BENZAMIDES DISUBSTITUÉS ET UTILISÉS COMME ACTIVATEURS DE LA GLUCOKINASE (GK)
Abstract: front page image
(EN)The invention relates to disubstituted benzamide derivatives of the general Formula (I), their pharmaceutically acceptable salts, pharmaceutically acceptable solvates, enantiomers, diastereomers, prodrugs, metabolites and polymorphs. The invention also relates to processes for the preparation of the compounds of the invention, pharmaceutical compositions containing the compounds and to methods for treating type II diabetes using the compounds of the invention.
(FR)L'invention concerne des dérivés de benzamides disubstitués de la formule générale (I), leurs sels pharmaceutiquement acceptables, leurs solvates pharmaceutiquement acceptables, leurs énantiomères, leurs diastéréomères, leurs promédicaments, leurs métabolites et leurs polymorphes. L'invention porte également sur des procédés de préparation des composés de l'invention, sur des compositions pharmaceutiques contenant ces composés et sur des méthodes de traitement du diabète de type II utilisant les composés de l'invention.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PE, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LR, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)